Vose, J M <br/><br/>
Phase I/II trial of PIXY321 to enhance engraftment following autologous bone marrow transplantation for lymphoid malignancy.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Feb 1996 
 - 520-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1996.14.2.520  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Bone Marrow Transplantation<br/>Female<br/>Graft Enhancement, Immunologic<br/>Granulocyte-Macrophage Colony-Stimulating Factor--administration & dosage<br/>Hodgkin Disease--therapy<br/>Humans<br/>Interleukin-3--administration & dosage<br/>Lymphoma, Non-Hodgkin--therapy<br/>Male<br/>Middle Aged<br/>Recombinant Fusion Proteins--administration & dosage<br/>Transplantation, Autologous